Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 30 results found. Search for [ FDC ]

Results 1 to 21 of 30
E Kumar Sharma
New Delhi, May 23, 2019
The pharma industry is today growing at around 11 per cent per annum as compared to a high of around 15 per cent about five years ago.


PTI
March 24, 2019



BusinessToday.In
February 22, 2019
Piramal Enterprises share price rose nearly 2% to 2,284 level compared to the previous close of 2,240.15 on the BSE. Piramal Enterprises share price has been gaining for the last five days and risen 4.41% during the period.


PTI
February 21, 2019



PTI
February 3, 2019



PTI
January 17, 2019



PTI
January 9, 2019



PTI
January 9, 2019



PTI
January 7, 2019



PTI
January 7, 2019



PTI
December 31, 2018



Renu Yadav
November 20, 2018
The fund house believes that these are interesting times for Indian healthcare sector despite disappointing earnings in FY18. The sector has the potential to get re-rated after temporary disruptions get resolved


PTI
October 31, 2018



BusinessToday.In
New Delhi, September 17, 2018
The decision was taken after drug makers filed a petition, saying that these drugs were being manufactured since 1988. They cited the SC's earlier relief to 15 manufacturers on the bases of the similar grounds, saying that they should also be exempted from the ban.


E Kumar Sharma
New Delhi, September 13, 2018
As the industry is trying to digest the development, not totally unexpected though, there are fresh concerns on what could come next as the ministry-appointed Prof Kokate Expert committee had discussed banning many more FDC drugs.


BusinessToday.In
New Delhi, September 13, 2018
India reportedly boasts around 2,000 FDCs, four times more that what's available in the US.


BusinessToday.In
New Delhi, September 13, 2018
The FDC medicines are two or more drugs contained in a single dosage form. The health ministry says it took the decision to ban these drugs after the Drugs Technical Advisory Board suggested these drugs might pose a risk to human beings.


E Kumar Sharma
New Delhi, June 8, 2018
The Indian pharma has recently seen a perceptible slide in the number of new products hitting the market. According to the analysts, slippages are more in select therapies and they attribute this to several reasons.


Joe C Mathew
December 18, 2017
The court's observation came during a hearing that challenged a Delhi High Court order that had quashed the government ban on technical grounds.


PTI
December 16, 2017



PAGES 1 OF 2  12